Children and road traffic injuries: can't the world do better?

Qingfeng Li1, Olakunle Alonge1, Adnan A Hyder1

  • 1Johns Hopkins International Injury Research Unit, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Insights

Globally, over 186,000 children die annually from road traffic injuries (RTI), with higher risks for males and children in low-income countries. Urgent implementation of road safety interventions is needed to reduce child mortality.

Area of Science:

  • Public Health
  • Pediatric Health
  • Injury Prevention

Background:

  • Road traffic injuries (RTI) represent a significant global child health issue, causing over 186,000 deaths annually in individuals under 18.
  • RTI is a leading cause of death for children and adolescents, particularly in sub-Saharan Africa, which accounts for 35.2% of global child fatalities.
  • Socioeconomic disparities exacerbate the problem, with 95% of child RTI deaths occurring in low- and middle-income countries (LMIC), disproportionately affecting children from impoverished households.

Purpose of the Study:

  • To highlight the substantial burden of road traffic injuries on child mortality worldwide.
  • To identify key demographic and socioeconomic factors contributing to child deaths from RTI.
  • To emphasize the need for implementing and validating existing road safety interventions in LMIC.

Main Methods:

  • This study synthesizes global data on child mortality due to road traffic injuries.
  • Analysis includes age-specific mortality rates, regional disparities (focusing on sub-Saharan Africa), and gender-based differences.
  • Socioeconomic factors, particularly the impact of low- and middle-income countries and household poverty, are examined.

Main Results:

  • Globally, 186,300 children under 18 die from RTI each year.
  • RTI is the leading cause of death for older children and adolescents (15-17 years) and a significant cause for younger age groups.
  • Male children face double the risk of death from RTI compared to females, and 95% of these deaths occur in LMIC.

Conclusions:

  • Road traffic injuries pose a critical and growing threat to child survival, especially in LMIC.
  • Existing intervention strategies, such as those from the Decade of Action for Road Safety, require urgent validation and implementation.
  • Achieving Sustainable Development Goals necessitates strengthened political will, advocacy, funding, and multisectoral collaboration to protect children from RTI.

Related Concept Videos

Survey Safety01:28

Survey Safety

Surveying near highways, rough terrain, or power lines involves significant risks. Working along highways is particularly dangerous and requires the use of warning signs and flagmen. It is safest to avoid working directly on roads and use offsets whenever possible. When highway work is unavoidable, it must follow all safety guidelines. Surveyors should wear bright clothing, such as orange reflective vests, to ensure visibility to motorists, coworkers, and hunters. In construction zones, wearing...
447
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
682
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351